OpenLobby.EU
Explore

Recommendation for strengthened actions against antimicrobial resistance

Public health

Antimicrobial resistance (AMR) is the ability of microorganisms, such as bacteria, to become increasingly resistant to antimicrobials, making them ineffective. AMR is a silent pandemic requiring urgent global action. The proposal aims at setting concrete objectives and activities to strengthen Member States action against AMR, mainly in the area of public health where the EU has only supporting and complementary competence.

Links

Public consultation

ID: 13322

Lobbying Activity

52 responses

Consultation response

American Chamber of Commerce to the European Union, 23 Mar 2022

Attached please find the feedback of The American Chamber of Commerce to the EU (AmCham EU) to the call for evidence on “Antimicrobial resistance – recommendation for greater action”.

Chemical industry urges recognition of disinfectants in AMR fight

European Chemical Industry Council, 23 Mar 2022

The organization seeks recognition that biocidal products like disinfectants and sanitizers are essential tools against antimicrobial resistance when used properly. They emphasize their products combat healthcare-associated infections and support infection prevention in hospitals, food processing, and farming.
This would protect their market for biocidal products in healthcare and industrial settings.

Consultation response

European farmers, 24 Mar 2022

Copa and Cogeca, representing EU farmers and agri-cooperatives, welcomes the possibility offered by the Commission to contribute to this public consultation. Please find our full feedback in the PDF attached.

Consultation response

European Federation of Pharmaceutical Industries and Associations, 23 Mar 2022

EFPIA welcomes the European Commission’s initiative to issue a proposed Council Recommendation on AMR. EFPIA supports the need for coordinated, effective and efficient “One Health” EU action to tackle AMR, focusing on high-impact areas, such as addressing market failures that have resulted in an…

Generic medicine industry seeks pricing reforms to combat antibiotic shortages

MEDICINES FOR EUROPE, 23 Mar 2022

The industry requests pricing and procurement reforms to ensure sustainable antibiotic supply, incentives for environmentally responsible manufacturing, and recognition of value-added innovation in existing antibiotics. They strongly oppose transferable exclusivity vouchers that would extend monopolies and delay generic access.
This would protect their market position and prevent price erosion from extreme cost-containment measures.
Healthcare systems lose potential savings from delayed generic entry on profitable blockbuster medicines.

Consultation response

MedTech Europe, 24 Mar 2022

Effective use of medical technologies can be part of the solution in fighting AMR caused by the over-and misuse of antibiotics and the spread of resistant strains. The effective use of diagnostic tests and medical devices can help to address these challenges by: • preventing and containing the…

Danish Agriculture urges science-based AMR strategy over consumption targets

Landbrug Fødevarer - Danish Agriculture and Food Council, 17 Mar 2022

The organization requests replacing reduction targets based on consumption with AMR action plans focused on high-impact interventions. They advocate for knowledge transfer from low-use countries and increased research on disease prevention and antibiotic alternatives.
This would let them avoid uniform reduction targets despite already having low antimicrobial usage.
Public health advocates lose clearer accountability through measurable consumption-based reduction targets.

Consultation response

Merck Sharp Dohme Europe Belgium SRL, 23 Mar 2022

MSD has a strong legacy in antimicrobial R&D. For more than 100 years, we have played a significant role in the discovery and development of medicines and vaccines to combat infectious diseases. MSD continues to focus on antimicrobial and vaccine R&D. Our broad portfolio spans both human and animal…

Consultation response

Vaccines Europe, 23 Mar 2022

Vaccines Europe, representing vaccine companies of all sizes operating in Europe welcomes the opportunity to take part in this public call for evidence on anti-microbial resistance (AMR). The European Commission proposal for a Council Recommendation on AMR goes into the right direction, and…

GSK urges market incentives and vaccines to combat antimicrobial resistance

GSK, 23 Mar 2022

GSK requests governments establish market-based solutions including transferable exclusivity extensions for new antibiotics, reform health technology assessment processes to recognize antibiotic value, and integrate vaccination programmes into national AMR action plans. They advocate for economic incentives that provide returns while maintaining low prescription volumes and subscription-based reimbursement models.
This would provide financial returns for their antibiotic and vaccine development while protecting patent exclusivity on other products.
Generic medicine producers lose as patent extensions delay affordable antibiotic access and competition.

European Public Health Alliance urges EU action on antimicrobial resistance crisis

European Public Health Alliance, 24 Mar 2022

The organization requests increased public funding for antibiotic development with conditions ensuring affordability and access. They advocate for delinking R&D costs from sales revenues and avoiding monopoly extensions. They also call for more support to help Member States develop and implement National Action Plans.
This would ensure new antibiotics remain affordable and accessible rather than restricted by monopolies.
Pharmaceutical companies lose monopoly extensions that allow them to charge higher prices for medicines.

Consultation response

Standing Committee of European Doctors, 23 Mar 2022

In preparation of the Commission proposal for a Council recommendation on AMR, please find below the European doctors’ feedback: In November 2020, CPME published the summary report about European doctors knowledge about antibiotics and AMR. The report is based on an ECDC survey, to which more than…

Consultation response

AnimalhealthEurope, 24 Mar 2022

AnimalhealthEurope represents the manufacturers of animal health products and services across Europe. As an industry we recognise the importance of tackling antimicrobial resistance in a One Health manner and ensuring the continued efficacy of antimicrobials. As a key contributor to One Health, we…

EU Feed Industry Urges Greater Role for Animal Nutrition in AMR Strategy

Fédération Européenne des Fabricants d'Aliments Composés, 22 Mar 2022

The organization requests that future AMR action plans give more attention to animal nutrition's role in reducing antibiotic use at farms. They argue for systematic use of animal nutrition expertise alongside veterinary advice, and for legal frameworks that stimulate innovation in feed additives and allow communication of nutrition solutions' health benefits to farmers.
This would expand their market for specialized feed products and additives targeting animal health.

Consultation response

Association Internationale de la Mutualité, 24 Mar 2022

AIM welcomes the opportunity to provide feedback on the EU initiative “Antimicrobial resistance – recommendation for greater action”. More information on our recommendations can be found in the attached statement, that we summarise as follows: New financing models for antibiotics are needed AMR…

Consultation response

Pharmaceutical Group of the European Union, 23 Mar 2022

European community pharmacists welcome the initiative for a new EU recommendation calling for greater action on Antimicrobial Resistance (AMR). By the cross-border nature of AMR, European community pharmacists believe the EU has a particular responsibility to lead an ambitious, multi-sectorial…

Consultation response

Cooperativas Agro-alimentarias de España, 10 Mar 2022

Antimicrobial resistance is a major problem facing European and global society, and one to which, most probably, insufficient attention has been paid by the international community in recent years. There is an international consensus that this problem has its origin in the inappropriate use of…

Confagricoltura favors rational drug use over simple reduction targets

Confederazione Generale dell'Agricoltura Italiana, 24 Mar 2022

The group favors rationalizing drug use instead of policies targeting simple quantity reductions. They propose improving diagnostics and biosecurity without adding new bureaucracy or costs. They argue that simple limitations could increase disease relapses and animal mortality.
Farmers would maintain production levels while avoiding additional regulatory and compliance costs.

Consultation response

League of European Research Universities, 24 Mar 2022

The League of European Research Universities (LERU), which brings together 23 of the leading research- intensive universities in Europe, welcomes this long overdue initiative from the European Commission. LERU considers that better financial support for AMR research and development, education and…

Consultation response

BEAM Alliance, 24 Mar 2022

The BEAM Alliance thanks the European Commission for the possibility to provide feedback on the Antimicrobial resistance- recommendation for greater action initiative. Inappropriate use of antimicrobial agents across human, animal, and environmental sectors accelerates the rise of antimicrobial…

Consultation response

European Federation of Nurses Associations, 25 Feb 2022

As nurses have closer and more frequent contact with patients and carers and undertake the role of care coordinator, they are ideally placed to lead antimicrobial resistance reduction and antimicrobial stewardship (AS) programmes. Nurses’ impact on AMR is immediately visible in their role as link…

Consultation response

LightingEurope, 23 Mar 2022

LightingEurope calls on European policymakers to actively support and stimulate the uptake of UV-C disinfection technologies to combat AMR, especially in health facilities and hospitals and to ensure that EU and national financial instruments are available to support their installation. UV-C…

Consultation response

Federation of Veterinarians of Europe, 22 Mar 2022

FVE welcomes the European Commission’s call for evidence without an impact assessment on antimicrobial resistance (AMR). Such an EU action should encompass a holistic and balanced ‘One Health’ approach that puts emphasis on safeguarding human health by ensuring animal, plant and environmental…

Consultation response

The European Association of Hospital Pharmacists, 21 Mar 2022

Attached please find the feedback of the European Association of Hospital Pharmacists to the call for evidence for an initiative on “Antimicrobial resistance – recommendation for greater action”.

Consultation response

Bundesärztekammer, 23 Mar 2022

The German Medical Association (Bundesärztekammer) represents approximately 537,000 physicians registered with the 17 State Chambers of Physicians (Landesärztekammern) in Germany. The German Medical Association welcomes the opportunity to comment on the Commission’s Roadmap for Council…

Consultation response

Institut national de recherche pour l’agriculture, l’alimentation et l’environnement, 24 Mar 2022

Please find attached INRAE's (French National Research Institute for Agriculture, Food and Environment) for this call for evidence to the forthcoming Council recommendation on a greater action towards antimicrobial resistance.

Consultation response

Biodynamic Federation Demeter International e.V., 16 Mar 2022

The Biodynamic Federation Demeter International welcomes this call for evidence on antimicrobial resistance (AMR) and would like to underline the importance to tackle this silent pandemic through concrete measures and actions at Member State level. The EU Council Recommendation must engage in an…

Consultation response

Federation of European Aquaculture Producers, 14 Mar 2022

The Federation of European Aquaculture Producers (FEAP) published in January 2022 its Position paper on Antimicrobial Resistance. Please read the full document attached.

Consultation response

BGP Products Operations GmbH – a Viatris Company, 24 Mar 2022

Many factors contribute to AMR, including poor infection control and over-prescribing of antibiotics. To fight AMR while ensuring patient access to life-saving medicines, the EC should consider the following evidence-based reforms: 1. Appropriate Use AMR is slowed when: • patients and HCPs…

Consultation response

Health Care Without Harm Europe, 16 Mar 2022

Health Care Without Harm (HCWH) Europe welcomes the opportunity to comment on the European Commission’s call for evidence on antimicrobial resistance (AMR) that aims to set concrete objectives and activities to strengthen national action against AMR, mainly in the area of public health where the EU…

FEFANA Urges Feed Nutrition Focus to Combat Antimicrobial Resistance

FEFANA, 24 Mar 2022

FEFANA highlights how specialty feed ingredients optimize animal nutrition and lower antibiotic reliance. They argue that adequate nutrition increases resilience and helps maintain high health standards.
This would promote specialty feed ingredients as essential tools for sustainable livestock production.
Manufacturers of therapeutic antibiotics may face lower demand for veterinary treatments.

Consultation response

Associazione delle Imprese del farmaco, 24 Mar 2022

Farmindustria, the Italian Association of Pharmaceutical Industries, welcomes the Commission's initiative for a Proposal for a Council Recommendation on antimicrobial resistance (AMR). The Covid-19 pandemic showed very clearly that infectious diseases, if no ready-to-use medicines and health…

Consultation response

Baxter Healthcare SA, 14 Mar 2022

Clinical Surveillance Software use should be maximised in the fight against Antimicrobial Resistance (AMR) Preventing infections, ensuring the right diagnosis early, and avoiding antimicrobials when they are not needed, can help stop the development and spread of antibiotic-resistant bacteria. Our…

Consultation response

European Biostimulants Industry Council, 24 Mar 2022

The European Biostimulants Industry Council (EBIC) would like to express the commitment of the plant biostimulants industry to avoid contributing to the problem of antimicrobial resistance (AMR). Although the use of microbial plant biostimulants is not considered to be a notable factor in the…

Consultation response

Becton Dickinson, 21 Mar 2022

Infection Prevention and Control: Lack of Harmonized Guidelines 1. Create a European Framework on HAI prevention and control. Within a broader European legislative framework on infection prevention and control, it is necessary to build consensus around evidence-based guidelines such as the one…

Consultation response

European Hospital and Healthcare Federation, 24 Mar 2022

HOPE welcomes the opportunity to comment on the European Commission’s call for evidence on antimicrobial resistance (AMR) aiming at the creation of a proposal for a Council Recommendation. Please find attached our detailed response. HOPE, the European Hospital and Healthcare Federation, is a…

Consultation response

Global Sepsis Alliance, 23 Mar 2022

The growing threat of antimicrobial resistance (AMR) is a major challenge in the treatment of sepsis. As more pathogens become resistant to available antibiotics, more people are at risk of developing sepsis from bacterial infections, and fewer opportunities exist for successful treatment. Without…

Consultation response

Cepheid Europe SAS, 22 Mar 2022

Cepheid is a global automated molecular diagnostics innovator, focused on the speed and accuracy of testing delivered closer to the patient. Our mission is to deliver a better way to improve patient outcomes by enabling access to PCR testing everywhere. At Cepheid we provide a wide portfolio of…

Consultation response

International Federation of Anthroposophic Medical Associations, 24 Mar 2022

The International Federation of Anthroposophic Medical Associations (IVAA) welcomes and supports the European Commission’s call for evidence for a recommendation on greater actions to tackle Antimicrobial Resistance. We are pleased to see the efforts for the uptake of already existing best…

Consultation response

Health First Europe, 24 Mar 2022

Health First Europe and the European Patient Group on Antimicrobial Resistance (https://healthfirsteurope.eu/topic/amr-patient-group/) welcome the opportunity to contribute to the Commission’s Call for Evidence. The AMR Patient Group includes 16 national patient associations from across Europe. The…

Consultation response

The Global Alliance for TB Drug Development, 23 Mar 2022

About TB Alliance: TB Alliance is a Product Development Partnership (PDP). PDPs are not-for-profits who develop drugs and technologies for people suffering from infectious diseases, poverty-related and neglected diseases in underserved markets, including new treatments for drug-resistant diseases.…

Consultation response

Hollandbio, 22 Mar 2022

Antibioticaresistentie (AMR) is een stille pandemie die jaar in jaar uit een groeiend aantal slachtoffers maakt en zich niets aantrekt van landsgrenzen. HollandBIO, de belangenvereniging van biotech bedrijven in Nederland, is blij dat de Europese Commissie de Europese Raad om formele aanbevelingen…

Consultation response

Ferring Pharmaceuticals Ltd, 21 Mar 2022

AMR is one of the gravest threats facing our healthcare systems today. Supporting the development of new antimicrobials whilst encouraging conservative use of existing therapies is necessary, but this can only be one limited part of the solution. As the Commission’s 2017 “One Health Action Plan…

Consultation response

Tuberculosis Vaccine Initiative, 17 Mar 2022

The TuBerculosis Vaccine Initiative (TBVI) welcomes the opportunity to comment on the European Commission’s call for evidence on antimicrobial resistance. TB remains one of the deadliest infectious disease in the world, killing 1.5 million each year. Around 10 million people develop TB disease…

Consultation response

ASOCIACIÓN NACIONAL EMPRESARIAL DE LA INDUSTRIA FARMACÉUTICA, 22 Mar 2022

FARMAINDUSTRIA, como representante de la industria farmacéutica innovadora establecida en España, comparte la preocupación del creciente reto que supone la resistencia antimicrobiana (AMR) para los sistemas sanitarios, así como la dificultad de abordar la I+D de nuevos antimicrobianos que cubran…

Consultation response

European Pharmaceutical Students' Association, 24 Mar 2022

By the cross-border nature of AMR, The European Pharmaceutical Students’ Association (EPSA) believe that the EU has a particular responsibility to lead an ambitious, multisectoral response, and assist the implementation of National Action Plans. Training the current and future health workforce is…

Consultation response

European Platform for the Responsible use of medicines in animals, 24 Mar 2022

EPRUMA is a multi-stakeholder platform working at European level since 2005 formed of veterinarians, farmers and agri-cooperatives, manufacturers of animal medicines and diagnostics, feed manufacturers, and professionals working in animal health, sanitary security and sustainable agriculture. Our…

Consultation response

European Sustainable Phosphorus Platform, 23 Mar 2022

ESPP (European Sustainable Phosphorus Platform) supports action to address inappropriate use of antibiotics and underlines that contamination of manure and sewage by pharmaceuticals and by ARG (antibiotic resistance genes) is a potential obstacle to recycling of nutrients and return of organic…

Consultation response

, 24 Mar 2022

Corbion acknowledges that antimicrobial resistance poses a serious risk to human and animal health and therefore applauds the European Commission’s initiative for greater action to combat antimicrobial resistance. To combat antimicrobial resistance, the EU must stimulate the development of new,…

Consultation response

Associazione Italiana Elettrosensibili, 24 Mar 2022

nella proposta raccomandazione non compare una sorgente (concausa) di resistenza agli antibiotici: LE RADIAZIONI ELETTROMAGNETICHE ARTIFICIALI. Copiosa letteratura scientifica (che qui ometto, ma facilmente individuabile tramite www.publimed.com) riporta studi di vitro e non su vari ceppi di…

Consultation response

TerraNova Energy GmbH, 17 Mar 2022

TerraNova Energy GmbH supports action to address inappropriate use of antibiotics and underlines that contamination of manure and sewage by pharmaceuticals and by ARG (antibiotic resistance genes) is a potential obstacle to recycling of nutrients and return of organic carbon to soil. Antibiotics,…

Consultation response

Time for Lyme ASBL, 14 Mar 2022

Lyme disease (including Borreliosis), which is transmitted to humans by infected ticks, is the most common zoonotic disease in Europe. It is often treated with antimicrobials, which work well if taken properly as of the first signs of infection (fatigue, fever, headache). However, if left…